Nanalysis Scientific Corp.

Equities

NSCI

CA63000Y1034

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. 12:59:59 2024-04-26 pm EDT 5-day change 1st Jan Change
0.44 CAD -2.22% Intraday chart for Nanalysis Scientific Corp. +18.92% +17.33%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Nanalysis Scientific Corp. Announces Resignation of Kham Lin as A Director CI
Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances CI
Nanalysis Scientific Corp. announced that it has received CAD 1 million in funding CI
Nanalysis Scientific Announces Financings MT
Nanalysis Scientific Brief: Announcing Up to $5 Million 'Best Efforts Prospectus Exempt Offering' Pursuant to the Listed Issuer Exemption and Up to $1 Million Concurrent Private Placement MT
Nanalysis Scientific Corp. announced that it expects to receive CAD 1 million in funding CI
Nanalysis Scientific Corp. to Seeks Acquisitions CI
Transcript : Nanalysis Scientific Corp. - Special Call
Nanalysis Scientific Corp. Provides Earnings Guidance for the Fourth Quarter 2023 CI
Transcript : Nanalysis Scientific Corp., Q3 2023 Earnings Call, Nov 30, 2023
Nanalysis Scientific Third-Quarter Loss Widens as Sales Rise MT
Nanalysis Scientific Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Nanalysis Scientific Corp., Q3 2023 Earnings Call, Nov 29, 2023
Transcript : Nanalysis Scientific Corp., Q2 2023 Earnings Call, Aug 25, 2023
Transcript : Nanalysis Scientific Corp., Q2 2023 Earnings Call, Aug 24, 2023
Nanalysis Scientific Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Nanalysis Scientific Enters into New Credit Facility with ATB Financial MT
Transcript : Nanalysis Scientific Corp. - Shareholder/Analyst Call
Transcript : Nanalysis Scientific Corp. - Special Call
Transcript : Nanalysis Scientific Corp., Q1 2023 Earnings Call, May 25, 2023
Nanalysis Scientific Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Nanalysis Scientific Corp. announced that it has received CAD 4.1287 million in funding CI
Transcript : Nanalysis Scientific Corp., Q4 2022 Earnings Call, Apr 27, 2023
Nanalysis Scientific Corp. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Nanalysis Scientific Corp.(TSXV:NSCI) dropped from S&P/TSX Venture Composite Index CI
Chart Nanalysis Scientific Corp.
More charts
Nanalysis Scientific Corp. is a Canada-based patent-protected technology company that develops, manufactures and sells magnetic resonance (MR) products for security, pharmaceutical, biotech, nutraceutical, chemical, food, materials, education, life science and medical applications. The Company operates through four segments: Nanalysis, RS2D, K’Prime and Corporate. The Company’s subsidiaries include Nanalysis Corp., Nanalysis GmbH, RS2D S.A.S., One Moon Scientific (OMS), K'(Prime) Technologies Inc., KPrime Group USA, KPrime Technologies, Quad Systems AG and Quad Systems Ltd. RS2D S.A.S. is a technology company that is specialized in the designing of compact, electronics components for a range of precision analytical MR instruments, including both NMR and magnetic resonance imaging (MRI). OMS is a software company, which is specialized in a suite of software tools to streamline and automate magnetic resonance data analysis and management.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.44 CAD
Average target price
1.2 CAD
Spread / Average Target
+172.73%
Consensus

Quarterly revenue - Rate of surprise